Compositions and methods for enhanced mucosal delivery of parathyroid hormone
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 17, 2007
Grant Date -
Dec 15, 2005
app pub date -
May 10, 2005
filing date -
May 10, 2004
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Pharmaceutical compositions and methods are described comprising at least a parathyroid hormone peptide (PTH) preferably PTH.sub.1-34 and one or more mucosal delivery-enhancing agents for enhanced nasal mucosal delivery of PTH, for treating or preventing osteoporosis or osteopenia in a mammalian subject, preferably a human.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully